Business

LHC: Strong H1-2025 results, robust cash flow, and major asset sale to boost shareholder returns

LHC: Strong H1-2025 results, robust cash flow, and major asset sale to boost shareholder returns

Life Healthcare Group Holdings LimitedMay 22, 20254
LHC: Strong H1-2025 results, robust cash flow, and major asset sale to boost shareholder returns

About this update from Life Healthcare Group Holdings Limited

Revenue grew 8.1% to R12.1bn, with EBITDA up 5.9% and NEPS up 9.1%. LMI sale to deliver significant proceeds, most of which will be returned to shareholders. FY2025 outlook targets 70% occupancy and further expansion. Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Life Healthcare Group Holdings Limited